Here, using the well-established ER-positive breast cancer cells, we demonstrated that ER-α66 protein was re-distributed from the cell nucleus to the cytoplasm and was destabilized presumably through the proteasome degradation system in ER-positive breast cancer stem/progenitor cells. This evidence concerns the gene ESR1 and breast carcinoma.